{"access":{"can_view":true,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":false,"can_get_doi":false,"can_share":true,"can_move":true,"can_move_outside":true,"can_transfer":true,"can_download":true,"is_locked":false},"authors":[{"name":"Paula  Aulicino","affiliation":"Hospital de Pediatria \"Prof. Dr. Juan P. Garrahan\"","affiliation_url":null,"username":"paula-aulicino","link":null,"image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""},"note":"","is_verified_author":true,"is_verified_user":true}],"before_start":"","book_chapter":null,"can_accept_authorship":false,"can_be_copied":true,"can_claim_authorship":false,"can_remove_fork":false,"can_sign":false,"child_steps":{},"cited_protocols":[],"collection_items":[],"created_on":1638878672,"creator":{"name":"Paula Aulicino","affiliation":"","affiliation_url":null,"username":"paula-aulicino","link":null,"image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""},"badges":[{"id":2,"name":"Author","image":{"source":"/img/badges/bronze.svg","placeholder":"/img/badges/bronze.svg"}},{"id":6,"name":"Science accelerator","image":{"source":"/img/badges/accelerator.svg","placeholder":"/img/badges/accelerator.svg"}}],"affiliations":[{"affiliation":null,"url":null,"is_default":true}]},"description":"{\"blocks\":[{\"key\":\"1fcqa\",\"text\":\"The protocol allows amplification and NGS sequencing of a PR-RT HIV-1 sequence using tagmentation strategy and Illumina MiSeq equipment, followed by analysis of drug-resistance associated mutations by HyDRA\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","disclaimer":"","document":"","documents":[],"doi":"dx.doi.org/10.17504/protocols.io.b2pjqdkn","doi_status":2,"fork_id":null,"fork_info":null,"forks":[],"funders":[],"groups":[{"id":37949,"uri":"hiv-genotypic-study-by-ngs-illumina","title":"HIV GENOTYPIC STUDY BY NGS (ILLUMINA)","image":{"source":"https://s3.amazonaws.com/protocols-files/files/1E7F0DEA575511EC91690A58A9FEAC02-placeholder.png","placeholder":"https://s3.amazonaws.com/protocols-files/files/1E7F0DEA575511EC91690A58A9FEAC02-placeholder.png"},"tech_support":{"email":null,"phone":null,"use_email":false,"hide_contact":false,"url":null}}],"guid":"C21A4160575511EC821CF7E279780D25","guidelines":"","has_references":true,"has_versions":false,"id":55755,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"image_attribution":"","in_trash":false,"is_bookmarked":false,"is_contact_suspended":false,"is_content_confidential":false,"is_content_warning":false,"is_in_transfer":false,"is_owner":true,"is_retracted":false,"is_shared_directly":false,"is_subprotocol":null,"is_unlisted":false,"item_id":852418,"journal":null,"journals":[],"keywords":null,"last_modified":1638882758,"link":"","location":null,"manuscript_citation":"","materials":[],"materials_text":"","ownership_history":null,"parent_collections":[],"parent_protocols":[],"peer_reviewed":false,"public":true,"public_fork_note":"","published_on":1638882758,"references":[{"step_number":"2","title":"HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.","doi":"https://doi.org/10.3851/IMP1571","authors":"Aulicino PC, Rocco CA, Mecikovsky D, Bologna R, Mangano A, Sen L"},{"step_number":"13","title":"A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance.","doi":"https://doi.org/10.1038/s41598-019-45328-3","authors":"Taylor T, Lee ER, Nykoluk M, Enns E, Liang B, Capina R, Gauthier MK, Domselaar GV, Sandstrom P, Brooks J, Ji H"}],"related_equipments":[{"name":"MiSeq","sku":"SY-410-1003","vendor":null}],"retraction_reason":null,"shared_access_id":100,"show_comparison":false,"sign_info":null,"state_version_id":236,"stats":{"is_voted":false,"number_of_views":66,"number_of_steps":14,"number_of_bookmarks":0,"number_of_comments":0,"number_of_bookmarked_comments":0,"number_of_steps_comments":0,"number_of_protocol_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"number_of_reagents":0,"number_of_equipments":1,"number_of_collections":0,"number_of_forks":{"private":0,"public":0},"number_of_accessible_forks":0},"status":{"id":1,"info":"We use this protocol and it’s working"},"steps":[{"id":1302244,"guid":"B591DF50575711EC821CF7E279780D25","previous_id":0,"previous_guid":null,"section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"cb3ki\",\"text\":\"Prepare the sample in BSL2 laboratory. This protocol can be used to amplify and sequence HIV-1 from plasma or culture supernatants, as well as from cell-associated HIV-1. In the latter, skip the step of reverse transcription and go straight to PCR amplification.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"1","cases":[],"critical":null},{"id":1302245,"guid":"B59317D0575711EC821CF7E279780D25","previous_id":1302244,"previous_guid":"B591DF50575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"jqbu\",\"text\":\"Perform reverse transcription of HIV-1 and PCR amplification of PR-RT 1168bp fragment using primers and conditions published in Aulicino et al, Antivir Ther 2010;15(4):641-50. PCR amplifications are performed in 25-cycle reactions to avoid introducing artificial mutations.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"18pv7\",\"text\":\" \",\"type\":\"atomic\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"7kacs\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"citation\",\"mutability\":\"\",\"data\":{\"authors\":\"Aulicino PC, Rocco CA, Mecikovsky D, Bologna R, Mangano A, Sen L\",\"can_edit\":1,\"date\":\"1262304000\",\"doi\":\"https://doi.org/10.3851/IMP1571\",\"guid\":\"6379ADA0575811EC821CF7E279780D25\",\"id\":1456,\"journal\":\"Antiviral therapy\",\"protocol_id\":\"0\",\"title\":\"HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.\"}}}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"2","cases":[],"critical":null},{"id":1302246,"guid":"B5938D01575711EC821CF7E279780D25","previous_id":1302245,"previous_guid":"B59317D0575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"1d9cl\",\"text\":\"Check second PCR products with agarose gel electrophoresis (1%). A single 1168bp band should be visible.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"3","cases":[],"critical":null},{"id":1302247,"guid":"B5947760575711EC821CF7E279780D25","previous_id":1302246,"previous_guid":"B5938D01575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"98rc\",\"text\":\"Perform purification of the PCR product with magnetic beads (Agencourt AMPure XP kit, Beckman Coulter, USA)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"4","cases":[],"critical":null},{"id":1302248,"guid":"B5953AB0575711EC821CF7E279780D25","previous_id":1302247,"previous_guid":"B5947760575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"d5hkn\",\"text\":\"Perform tagmentation and indexation with Nextera XT DNA Library Preparation Kit (Illumina, San Diego, CA, USA), following manufacturer´s instructions.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"5","cases":[],"critical":null},{"id":1302249,"guid":"B5962510575711EC821CF7E279780D25","previous_id":1302248,"previous_guid":"B5953AB0575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"cku79\",\"text\":\"Check electrophoresis tagmentation patterns with QIAxel or another similar equipment. If none is available, a polyacrylamide gel can be used.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"6","cases":[],"critical":null},{"id":1302250,"guid":"B5970F71575711EC821CF7E279780D25","previous_id":1302249,"previous_guid":"B5962510575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"t5fv\",\"text\":\"Quantify DNA using the fluorometric Qubit dsDNA high-sensitivity (HS) assay (Qubit 1X dsDNA HS Assay Kit, ThermoFisher Scientific, USA)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"7","cases":[],"critical":null},{"id":1302251,"guid":"B59847F0575711EC821CF7E279780D25","previous_id":1302250,"previous_guid":"B5970F71575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"espa6\",\"text\":\"Calculate PCR samples concentration and volume to normalize all samples to 2nM, using PCR water.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"8","cases":[],"critical":null},{"id":1302252,"guid":"B5998071575711EC821CF7E279780D25","previous_id":1302251,"previous_guid":"B59847F0575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"bppvo\",\"text\":\"Pool all samples using 5ul of each 2nM dilution of each sample.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"9","cases":[],"critical":null},{"id":1302253,"guid":"B59AE000575711EC821CF7E279780D25","previous_id":1302252,"previous_guid":"B5998071575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"firvp\",\"text\":\"Prepare PhiX at 12.5 pM. Dilute the library to 8 picomolar in HT1 buffer, and add 20% of PhiX. The purpose of PhiX is to add diversity to the samples.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"10","cases":[],"critical":null},{"id":1302254,"guid":"DED07F20575711EC821CF7E279780D25","previous_id":1302253,"previous_guid":"B59AE000575711EC821CF7E279780D25","section":"","section_color":"","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"5vf99\",\"text\":\"Run in Illumina MiSeq\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7187a\",\"text\":\" \",\"type\":\"atomic\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"7rit9\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"equipment\",\"mutability\":\"\",\"data\":{\"id\":206,\"brand\":\"illumina\",\"can_edit\":0,\"guid\":\"EEEEC740575711EC821CF7E279780D25\",\"link\":\"https://www.illumina.com/systems/sequencing-platforms/miseq/order-miseq.html\",\"name\":\"MiSeq\",\"sku\":\"SY-410-1003\",\"specifications\":\"\",\"type\":\"Sequencer\",\"vendor\":{\"id\":0,\"name\":\"\",\"link\":\"\",\"image\":{\"source\":\"\",\"placeholder\":\"\"}},\"file\":null,\"image\":{\"id\":31843,\"source\":\"https://s3.amazonaws.com/pr-journal/9dd3sqe.jpg\",\"name\":\"miseq.jpg\",\"icon\":\"https://www.protocols.io/img/extensions/jpg.png\"}}}}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"11","cases":[],"critical":null},{"id":1302255,"guid":"6C67C000575811EC821CF7E279780D25","previous_id":1302254,"previous_guid":"DED07F20575711EC821CF7E279780D25","section":"\u003cp\u003eControls and Error Rate calculation\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"as5c8\",\"text\":\"pNL4-3 HIV-1 was used as control. Using BWA, align fastq reads belonging to the control sample to the reference pNL4-3 HIV-1 genome (GenBank Accession Number AF324493). Calculate the average number of mismatches/ total bases. Error Rate should not exceed 0,5%. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"12","cases":[],"critical":null},{"id":1302270,"guid":"147500B0575D11EC821CF7E279780D25","previous_id":1302255,"previous_guid":"6C67C000575811EC821CF7E279780D25","section":"\u003cp\u003eSequence analysis using HyDRA\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"n3ls\",\"text\":\"HyDRA (https://hydra.canada.ca/pages/home?lang=en-CA) is an annotated reference-based bioinformatics pipeline scripted in Perl, which analyses next generation sequencing (NGS) data for genotyping HIV-1 drug resistance (HIVDR) mutations. It utilizes an annotated HXB2 sequence (GenBank Accession number: K03455) for reference mapping by Bowtie2 2 , and stringent data quality assurance and variant calling criteria to identify HIVDR associated mutations based on the Stanford HIV Drug Resistance Database (http://hivdb.stanford.edu/) and 2009 WHO list for Surveillance of Transmitted HIVDR. All HIVDR mutations found in the pol genes; protease (PR), reverse transcriptase (RT), and integrase (IN), are reported according to classifications outlined in the Stanford Surveillance Drug Resistance Mutation list .\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":7,\"length\":45}],\"data\":{}},{\"key\":\"4tfjv\",\"text\":\" \",\"type\":\"atomic\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":1,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"5l4qc\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"\",\"data\":{\"guid\":\"CD08D111575D11EC91690A58A9FEAC02\",\"url\":\"https://hydra.canada.ca/pages/home?lang=en-CA\"}},\"1\":{\"type\":\"citation\",\"mutability\":\"\",\"data\":{\"authors\":\"Taylor T, Lee ER, Nykoluk M, Enns E, Liang B, Capina R, Gauthier MK, Domselaar GV, Sandstrom P, Brooks J, Ji H\",\"can_edit\":1,\"date\":\"1560988800\",\"doi\":\"https://doi.org/10.1038/s41598-019-45328-3\",\"guid\":\"9D48ED20575D11EC821CF7E279780D25\",\"id\":1457,\"journal\":\"Scientific reports\",\"protocol_id\":\"0\",\"title\":\"A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance.\"}}}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"13","cases":[],"critical":null},{"id":1302285,"guid":"D3989510575D11EC821CF7E279780D25","previous_id":1302270,"previous_guid":"147500B0575D11EC821CF7E279780D25","section":"\u003cp\u003eSequence analysis using HyDRA\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"ad05r\",\"text\":\"Submit sequences to HyDRA. The following Advanced options for Nextera seqs can be used to inform amino acids in 1% frequency or higher, with a minimum read depth of 1000 x:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9gjqb\",\"text\":\"Consensus percent: 20\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"d0jsk\",\"text\":\"Target coverage: -1\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4a6hr\",\"text\":\"Length cutoff: 100\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"3ne8v\",\"text\":\"Score cutoff: 2\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9hf2i\",\"text\":\"Error rate: include error rate calculated with the control (e.g. 0.005)\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"casi0\",\"text\":\"Minimum variant quality: 20\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7gc8e\",\"text\":\"Minimum read depth: 1000\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ace81\",\"text\":\"Minimum allele count: 7\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"blh96\",\"text\":\"Minimum amino acid frequency: 0.01 \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":55755,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"14","cases":[],"critical":null}],"template_id":1,"title":"Nextera XT protocol for MiSeq HIVPR-RT sequencing","title_html":"\u003cp\u003eNextera XT protocol for MiSeq HIV\u003csup\u003ePR-RT\u003c/sup\u003e sequencing\u003c/p\u003e","type_id":1,"units":[{"id":1,"type_id":3,"name":"µL","can_manage":0},{"id":2,"type_id":3,"name":"mL","can_manage":0},{"id":3,"type_id":3,"name":"L","can_manage":0},{"id":4,"type_id":3,"name":"µg","can_manage":0},{"id":5,"type_id":3,"name":"mg","can_manage":0},{"id":6,"type_id":3,"name":"g","can_manage":0},{"id":7,"type_id":3,"name":"kg","can_manage":0},{"id":8,"type_id":3,"name":"ng","can_manage":0},{"id":9,"type_id":3,"name":"Hz","can_manage":0},{"id":10,"type_id":24,"name":"°C","can_manage":0},{"id":11,"type_id":24,"name":"°К","can_manage":0},{"id":12,"type_id":24,"name":"°F","can_manage":0},{"id":13,"type_id":25,"name":"Mass Percent","can_manage":0},{"id":14,"type_id":25,"name":"% volume","can_manage":0},{"id":15,"type_id":25,"name":"Mass / % volume","can_manage":0},{"id":16,"type_id":25,"name":"Parts per Million (PPM)","can_manage":0},{"id":17,"type_id":25,"name":"Parts per Billion (PPB)","can_manage":0},{"id":18,"type_id":25,"name":"Parts per Trillion (PPT)","can_manage":0},{"id":19,"type_id":25,"name":"Mole Fraction","can_manage":0},{"id":20,"type_id":25,"name":"Mole Percent","can_manage":0},{"id":21,"type_id":25,"name":"Molarity (M)","can_manage":0},{"id":22,"type_id":25,"name":"Molarity (m)","can_manage":0},{"id":23,"type_id":25,"name":"Genome copies per ml","can_manage":0},{"id":24,"type_id":3,"name":"μV","can_manage":0},{"id":25,"type_id":3,"name":"ms","can_manage":0},{"id":26,"type_id":3,"name":"pg","can_manage":0},{"id":27,"type_id":25,"name":"Molarity dilutions","can_manage":0},{"id":28,"type_id":25,"name":"millimolar (mM)","can_manage":0},{"id":29,"type_id":25,"name":"micromolar (µM)","can_manage":0},{"id":30,"type_id":25,"name":"nanomolar (nM)","can_manage":0},{"id":31,"type_id":25,"name":"picomolar (pM)","can_manage":0},{"id":32,"type_id":24,"name":"Room temperature","can_manage":0},{"id":33,"type_id":30,"name":"rpm","can_manage":0},{"id":34,"type_id":30,"name":"x g","can_manage":0},{"id":165,"type_id":24,"name":"On ice","can_manage":0},{"id":200,"type_id":32,"name":"cm","can_manage":0},{"id":201,"type_id":32,"name":"mm","can_manage":0},{"id":202,"type_id":32,"name":"µm","can_manage":0},{"id":203,"type_id":32,"name":"nm","can_manage":0},{"id":204,"type_id":25,"name":"mg/mL","can_manage":0},{"id":205,"type_id":25,"name":"µg/µL","can_manage":0},{"id":206,"type_id":25,"name":"% (v/v)","can_manage":0},{"id":1324,"type_id":30,"name":"rcf","can_manage":0},{"id":1359,"type_id":35,"name":"Bar","can_manage":0},{"id":1360,"type_id":35,"name":"Pa","can_manage":0}],"uri":"nextera-xt-protocol-for-miseq-hivpr-rt-sequencing-b2pjqdkn","url":"https://www.protocols.io/view/nextera-xt-protocol-for-miseq-hivpr-rt-sequencing-b2pjqdkn","version_class":55755,"version_data":{"id":0,"code":"b2pjqdkn","version_class":55755,"parent_id":null,"parent_uri":null,"is_same_owner":false,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":false,"merge_request":null},"version_id":0,"version_uri":"nextera-xt-protocol-for-miseq-hivpr-rt-sequencing-q26g74zk8gwz/v1","versions":[{"id":55755,"title":"Nextera XT protocol for MiSeq HIVPR-RT sequencing","title_html":"\u003cp\u003eNextera XT protocol for MiSeq HIV\u003csup\u003ePR-RT\u003c/sup\u003e sequencing\u003c/p\u003e","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.b2pjqdkn","uri":"nextera-xt-protocol-for-miseq-hivpr-rt-sequencing-b2pjqdkn","published_on":1638882758,"modified_on":1638882758,"version_class":55755,"version_id":0,"version_code":"b2pjqdkn","version_uri":"nextera-xt-protocol-for-miseq-hivpr-rt-sequencing-q26g74zk8gwz/v1","created_on":1638878672,"categories":null,"creator":{"name":"Paula Aulicino","affiliation":null,"affiliation_url":null,"username":"paula-aulicino","link":null,"image":{"source":"/img/avatars/010.png","placeholder":"/img/avatars/010.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}}],"warning":""}